Under construction – not a live service
Sign in
Taking people in SwitzerlandPhase 4

Tests low-dose ketamine during surgery for endometriosis pain

Tests low-dose ketamine given during keyhole surgery in adults with endometriosis.

Plain-language title generated from the registry record
Registry title: Endometriosis and Pain Treatment by Intraoperative Administration of Low-dose Ketamine

Key facts

Where
Bern, SwitzerlandSee the site
Phase
Phase 4

Where in Switzerland

  • Inselspital BernBern, SwitzerlandTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Insel Gruppe AG, University Hospital Bern
Trial code
NCT06951802
Record updated
30 April 2025
Original description
RCT comparing intraoperative administration of low-dose ketamine during laparoscopic endometriosis operation and the postoperative pain outcomeRead full original descriptionShow less

Endometriosis and Pain Treatment by Intraoperative Administration of Low-dose Ketamine A Single-Centre, Prospective, Randomized, Controlled Trial

RCT comparing intraoperative administration of low-dose ketamine during laparoscopic endometriosis operation and the postoperative pain outcome

Inclusion: Patients undergoing surgery for endometriosis operation requiring general anaesthesia at the Inselspital, Bern University Hospital, University of Bern, Department of gynaecology and obstetrics; Age ≥ 18 years; American Society of Anesthesiologist (ASA) physical status 1-3; Patients with known or suspected endometriosis; Written informed consent.

Exclusion: Myocardial infarction during the last 30 days prior to surgery; Liver disease; Known malignant hyperthermia; Cardiovascular instability or severe heart failure (New York Heart Association classification (NYHA) > III); Limited peripheral autonomic activity, hypersensitivity to ketamine or propofol or its components; Age < 18 years; ASA physical status ≥4; Higher-grade atrioventricular block without pacemaker; Severe hypovolemia or bradycardia; Uncontrolled hyper- or hypotension; Increased intracranial or increased intraocular pressure; Pregnancy; Rejection or lack of consent of the patient or relatives.

ClinicalTrials.gov NCT06951802